|
ABOUT COMPANY
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel technologies and therapies for the treatment of central nervous system, respiratory, and other disorders. The company is headquartered in New York, New York.
|
EARNINGS
Gross Profit (TTM): -10984000
Market Capitalization: 171957000
Operating Margin (TTM): 0
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0
Revenue (TTM): 0
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.577
Dividend Date: 2019-01-24
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: None
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|